pomalidomide has been researched along with chir 99021 in 1 studies
Studies (pomalidomide) | Trials (pomalidomide) | Recent Studies (post-2010) (pomalidomide) | Studies (chir 99021) | Trials (chir 99021) | Recent Studies (post-2010) (chir 99021) |
---|---|---|---|---|---|
623 | 121 | 552 | 272 | 1 | 258 |
Protein | Taxonomy | pomalidomide (IC50) | chir 99021 (IC50) |
---|---|---|---|
G2/mitotic-specific cyclin-B2 | Homo sapiens (human) | 8.8 | |
Cyclin-dependent kinase 1 | Homo sapiens (human) | 8.8 | |
G2/mitotic-specific cyclin-B1 | Homo sapiens (human) | 8.8 | |
Glycogen synthase kinase-3 alpha | Homo sapiens (human) | 0.0089 | |
Glycogen synthase kinase-3 beta | Homo sapiens (human) | 0.0133 | |
G2/mitotic-specific cyclin-B3 | Homo sapiens (human) | 8.8 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Feng, F; Jiang, X; Liu, X; Sun, H; Wang, Y; Xu, J; Xu, K; Zhou, J | 1 |
1 other study(ies) available for pomalidomide and chir 99021
Article | Year |
---|---|
PROTACs suppression of GSK-3β, a crucial kinase in neurodegenerative diseases.
Topics: Animals; Enzyme Inhibitors; Glycogen Synthase Kinase 3 beta; HT29 Cells; Humans; Models, Molecular; Neurodegenerative Diseases; PC12 Cells; Proteolysis; Rats; Small Molecule Libraries | 2021 |